相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Recent Progress in the Therapeutic Role of Serelaxin in Vascular Dysfunction
Ghulam Murtaza et al.
CURRENT PROTEIN & PEPTIDE SCIENCE (2018)
The relaxin receptor as a therapeutic target - perspectives from evolution Cheek for updates and drug targeting
Ross A. D. Bathgate et al.
PHARMACOLOGY & THERAPEUTICS (2018)
Heart Disease and Relaxin: New Actions for an Old Hormone
Teja Devarakonda et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2018)
Vascular actions of relaxin: nitric oxide and beyond
C. H. Leo et al.
BRITISH JOURNAL OF PHARMACOLOGY (2017)
The actions of relaxin on the human cardiovascular system
Mohsin Sarwar et al.
BRITISH JOURNAL OF PHARMACOLOGY (2017)
Serelaxin in acute heart failure: Most recent update on clinical and preclinical evidence
Raktim Kumar Ghosh et al.
CARDIOVASCULAR THERAPEUTICS (2017)
Non-nuclear estrogen receptor alpha activation in endothelium reduces cardiac ischemia-reperfusion injury in mice
Sara Menazza et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2017)
Serelaxin in clinical development: past, present and future
Elaine Unemori
BRITISH JOURNAL OF PHARMACOLOGY (2017)
Additive cardioprotection by pharmacological postconditioning with hydrogen sulfide and nitric oxide donors in mouse heart: S-sulfhydration vs. S-nitrosylation
Junhui Sun et al.
CARDIOVASCULAR RESEARCH (2016)
The Anti-fibrotic Actions of Relaxin Are Mediated Through a NO-sGC-cGMP-Dependent Pathway in Renal Myofibroblasts In Vitro and Enhanced by the NO Donor, Diethylamine NONOate
Chao Wang et al.
FRONTIERS IN PHARMACOLOGY (2016)
Ischaemic preconditioning preferentially increases protein S-nitrosylation in subsarcolemmal mitochondria
Junhui Sun et al.
CARDIOVASCULAR RESEARCH (2015)
Molecular Signature of Nitroso-Redox Balance in Idiopathic Dilated Cardiomyopathies
Sara Menazza et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2015)
Heart Disease and Stroke Statistics-2015 Update A Report From the American Heart Association
Dariush Mozaffarian et al.
CIRCULATION (2015)
Diverse Regulation of Cardiac Expression of Relaxin Receptor by α1- and β1-Adrenoceptors
Xiao-Lei Moore et al.
CARDIOVASCULAR DRUGS AND THERAPY (2014)
Serelaxin Is a More Efficacious Antifibrotic Than Enalapril in an Experimental Model of Heart Disease
Chrishan S. Samuel et al.
HYPERTENSION (2014)
Signaling by S-nitrosylation in the heart
Elizabeth Murphy et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2014)
Heart failure: preventing disease and death worldwide
Piotr Ponikowski et al.
ESC HEART FAILURE (2014)
Relaxin Suppresses Atrial Fibrillation by Reversing Fibrosis and Myocyte Hypertrophy and Increasing Conduction Velocity and Sodium Current in Spontaneously Hypertensive Rat Hearts
Ashish Parikh et al.
CIRCULATION RESEARCH (2013)
Effects of serelaxin in subgroups of patients with acute heart failure: results from RELAX-AHF
Marco Metra et al.
EUROPEAN HEART JOURNAL (2013)
Essential role of nitric oxide in acute ischemic preconditioning: S-Nitros(yl)ation versus sGC/cGMP/PKG signaling?
Junhui Sun et al.
FREE RADICAL BIOLOGY AND MEDICINE (2013)
Effect of Serelaxin on Cardiac, Renal, and Hepatic Biomarkers in the Relaxin in Acute Heart Failure (RELAX-AHF) Development Program Correlation With Outcomes
Marco Metra et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2013)
Serelaxin, recombinant human relaxin-2, for treatment of acute heart failure (RELAX-AHF): a randomised, placebo-controlled trial
John R. Teerlink et al.
LANCET (2013)
RELAXIN FAMILY PEPTIDES AND THEIR RECEPTORS
R. A. D. Bathgate et al.
PHYSIOLOGICAL REVIEWS (2013)
Identification and optimization of small-molecule agonists of the human relaxin hormone receptor RXFP1
Jingbo Xiao et al.
NATURE COMMUNICATIONS (2013)
Disruption of Caveolae Blocks Ischemic Preconditioning-Mediated S-Nitrosylation of Mitochondrial Proteins
Junhui Sun et al.
ANTIOXIDANTS & REDOX SIGNALING (2012)
Regulation of cardiovascular cellular processes by S-nitrosylation
Ivonne Hernandez Schulman et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2012)
beta 2 adrenergic activation induces the expression of IL-18 binding protein, a potent inhibitor of isoproterenol induced cardiomyocyte hypertrophy in vitro and myocardial hypertrophy in vivo
David R. Murray et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2012)
Dynamic denitrosylation via S-nitrosoglutathione reductase regulates cardiovascular function
Farideh Beigi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Cardiac Dysfunction and Noncardiac Dysfunction as Precursors of Heart Failure With Reduced and Preserved Ejection Fraction in the Community
Carolyn S. P. Lam et al.
CIRCULATION (2011)
Cardiomyocyte-Specific Deletion of the Vitamin D Receptor Gene Results in Cardiac Hypertrophy
Songcang Chen et al.
CIRCULATION (2011)
Protein S-Nitrosylation and Cardioprotection
Junhui Sun et al.
CIRCULATION RESEARCH (2010)
S-Nitrosylation in Cardiovascular Signaling
Brian Lima et al.
CIRCULATION RESEARCH (2010)
S-Nitrosylation Regulates Nuclear Translocation of Chloride Intracellular Channel Protein CLIC4
Mariam Malik et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Nitric oxide inhibits platelet adhesion to collagen through cGMP-dependent and independent mechanisms: The potential role for S-nitrosylation
Catherine Irwin et al.
PLATELETS (2009)
Preconditioning results in S-nitrosylation of proteins involved in regulation of mitochondrial energetics and calcium transport
Junhui Sun et al.
CIRCULATION RESEARCH (2007)
Role of AT1 receptor in isoproterenol-induced cardiac hypertrophy and oxidative stress in mice
Guo-Xing Zhang et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2007)
The effects of relaxin and estrogen deficiency on collagen deposition and hypertrophy of nonreproductive organs
Edna D. Lekgabe et al.
ENDOCRINOLOGY (2006)
Hypercontractile female hearts exhibit increased S-nitrosylation of the L-type Ca2+ channel α1 subunit and reduced ischemia/reperfusion injury
JH Sun et al.
CIRCULATION RESEARCH (2006)
S-nitrosylation: NO-related redox signaling to protect against oxidative stress
Junhui Sun et al.
ANTIOXIDANTS & REDOX SIGNALING (2006)
Nitric oxide regulates transforming growth factor-β signaling in endothelial cells
M Saura et al.
CIRCULATION RESEARCH (2005)
Relaxin: Antifibrotic Properties and Effects in Models of Disease
Chrishan S. Samuel
CLINICAL MEDICINE & RESEARCH (2005)
Relaxin modulates cardiac fibroblast proliferation, differentiation, and collagen production and reverses cardiac fibrosis in vivo
CS Samuel et al.
ENDOCRINOLOGY (2004)
Increased myocardial collagen and ventricular diastolic dysfunction in relaxin deficient mice: a gender-specific phenotype
XJ Du et al.
CARDIOVASCULAR RESEARCH (2003)
S-nitrosylation of matrix metalloproteinases: Signaling pathway to neuronal cell death
ZZ Gu et al.
SCIENCE (2002)
Activation of orphan receptors by the hormone relaxin
SY Hsu et al.
SCIENCE (2002)
Calcium regulates S-nitrosylation, denitrosylation, and activity of tissue transglutaminase
TS Lai et al.
BIOCHEMISTRY (2001)
分享论文
